# GALECTIN THERAPEUTICS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/galectin-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-26T14:46:49.514217+00:00 | | Last reviewed | 2026-10-26T14:46:49.514217+00:00 | ## Identity - Legal name: GALECTIN THERAPEUTICS INC - Display name: GALECTIN THERAPEUTICS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-26T19:45:44.847474+00:00 | | Completeness | 0.409 | | Record Quality | 0.846 | | Directors | 10 | | Committees | 5 | | Governance events | 18 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Benjamin S. Carson, Sr., M.D.: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:5 - Elissa J. Schwartz, Ph.D.: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:6 - Gilbert F. Amelio, Ph.D.: Director. Status: current. Independent: true. Since: 2009-01-01. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:7 - Harold H. Shlevin, Ph.D.: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:8 - Joel Lewis: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:9 - Kary Eldred: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (member). claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:10 - Kevin D. Freeman: Director. Status: current. Independent: true. Since: 2011-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:11 - Marc Rubin, M.D.: Director. Status: current. Independent: true. Since: 2011-01-01. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:12 - Richard A. Zordani: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:13 - Richard E. Uihlein: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:14 ## Committees - Audit (audit). Chair: Richard A. Zordani. Members: Richard A. Zordani (chair, current); Kary Eldred (member, current); Kevin D. Freeman (member, current). committee_id=alpha:committee:galectin-therapeutics-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Richard A. Zordani (member, current). committee_id=alpha:committee:galectin-therapeutics-inc:audit-chair - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Kevin D. Freeman (member, current). committee_id=alpha:committee:galectin-therapeutics-inc:audit-compensation-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Kevin D. Freeman (member, current). committee_id=alpha:committee:galectin-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Kevin D. Freeman (member, current). committee_id=alpha:committee:galectin-therapeutics-inc:nominating-and-governance ## Executive leadership - Jack W. Callicutt: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:15 - Joel Lewis: Chief Executive Officer and President [CEO]. Status: current. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:16 - Khurram Jamil, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:17 ## Governance events - CFO_CHANGED: Jack W. Callicutt executive of GALECTIN THERAPEUTICS INC, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:pbh8387gnezq - CEO_CHANGED: Joel Lewis executive of GALECTIN THERAPEUTICS INC, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:ux0ehkvl38qw - EXECUTIVE_APPOINTED: Khurram Jamil, M.D. executive of GALECTIN THERAPEUTICS INC, effective 2026-03-31. Effective: 2026-03-31. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:nyipxv127tibp - DIRECTOR_APPOINTED: Benjamin S. Carson, Sr., M.D. seat on GALECTIN THERAPEUTICS INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:1629gou1doxv7e - DIRECTOR_APPOINTED: Elissa J. Schwartz, Ph.D. seat on GALECTIN THERAPEUTICS INC, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:5dpgjs1gd65am - DIRECTOR_APPOINTED: Richard A. Zordani seat on GALECTIN THERAPEUTICS INC, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:zcpu04p15ha2 - COMMITTEE_CREATED: Audit · Chair committee of GALECTIN THERAPEUTICS INC, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:2p8uuyt736ue - COMMITTEE_MEMBER_ADDED: Richard A. Zordani member of Audit · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:12pgxn51nai3in - DIRECTOR_APPOINTED: Harold H. Shlevin, Ph.D. seat on GALECTIN THERAPEUTICS INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:1kr1ymsgnrq3u - DIRECTOR_APPOINTED: Kary Eldred seat on GALECTIN THERAPEUTICS INC, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:1ha2k84vxhky - COMMITTEE_MEMBER_ADDED: Kary Eldred member of Audit, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:ogzucepxqd0 - DIRECTOR_APPOINTED: Joel Lewis seat on GALECTIN THERAPEUTICS INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:15lqgjj1kslv8l - DIRECTOR_APPOINTED: Richard E. Uihlein seat on GALECTIN THERAPEUTICS INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:vu0nupjwwka5 - DIRECTOR_APPOINTED: Kevin D. Freeman seat on GALECTIN THERAPEUTICS INC, effective 2011-01-01. Effective: 2011-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:w3bncy1wb3rd2 - DIRECTOR_APPOINTED: Marc Rubin, M.D. seat on GALECTIN THERAPEUTICS INC, effective 2011-01-01. Effective: 2011-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:nypg951nuuph1 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of GALECTIN THERAPEUTICS INC, effective 2011-01-01. Effective: 2011-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:103mx7218cyq6 - COMMITTEE_MEMBER_ADDED: Kevin D. Freeman member of Audit; Compensation; Nominating and Governance, effective 2011-01-01. Effective: 2011-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:n7ihlu1s9otb0 - DIRECTOR_APPOINTED: Gilbert F. Amelio, Ph.D. seat on GALECTIN THERAPEUTICS INC, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-26T14:46:49.514217+00:00. event_id=alpha:event:transition:c6bn2edb95jw ## Scoped resources - `alpha://company/galectin-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record - `alpha://company/galectin-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=identity - `alpha://company/galectin-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/galectin-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=board - `alpha://company/galectin-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=committees - `alpha://company/galectin-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=leadership - `alpha://company/galectin-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=ownership - `alpha://company/galectin-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=financials - `alpha://company/galectin-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/galectin-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=compensation - `alpha://company/galectin-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=governance - `alpha://company/galectin-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/galectin-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=audit - `alpha://company/galectin-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=legal - `alpha://company/galectin-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=risk - `alpha://company/galectin-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=cyber - `alpha://company/galectin-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/galectin-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=agents - `alpha://company/galectin-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/galectin-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=events - `alpha://company/galectin-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=relationships - `alpha://company/galectin-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=assessments - `alpha://company/galectin-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:richard-a-zordani","name":"Richard A. Zordani"},"source_id":"board_seats"}` - Claim alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:kary-eldred","name":"Kary Eldred"},"source_id":"board_seats"}` - Claim alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:kevin-d-freeman","name":"Kevin D. Freeman"},"source_id":"board_seats"}` - Claim alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kevin-d-freeman","name":"Kevin D. Freeman"},"source_id":"board_seats"}` - Claim alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:kevin-d-freeman","name":"Kevin D. Freeman"},"source_id":"board_seats"}` ## Leadership - Benjamin S. Carson, Sr., M.D.: Director. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:5. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Elissa J. Schwartz, Ph.D.: Director. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Gilbert F. Amelio, Ph.D.: Director. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:7. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Harold H. Shlevin, Ph.D.: Director. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Joel Lewis: Director. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Kary Eldred: Director, Audit. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Kevin D. Freeman: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:11. Valid from: 2011-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Marc Rubin, M.D.: Director. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:12. Valid from: 2011-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Richard A. Zordani: Director, Audit · Chair. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Richard E. Uihlein: Director. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:14. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff. - Jack W. Callicutt: Chief Financial Officer. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:15. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9f663de825e5cf32461de1d780da5fea1dd5881323c905be6a382c6d7aa6b907. - Joel Lewis: Chief Executive Officer and President. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:16. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9411ad063b6db76d3e745ef7e598845d34d8f8b33a1d49f6c38ef2f8d2d73959. - Khurram Jamil, M.D.: Chief Medical Officer. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:leadership_role:17. Valid from: 2026-03-31. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:55dcc4d5e4ed3af9afd348edbc43fe47338442f6800df0365f5c5bda107509f1. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Richard A. Zordani; Members Richard A. Zordani (Chair); Kary Eldred; Kevin D. Freeman. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. - Compensation: Chair not stated; Members Kevin D. Freeman. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. - Nominating and Governance: Chair not stated; Members Kevin D. Freeman. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - GALECTIN THERAPEUTICS INC. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2204a7ef3a119f1804148cd98f27d5d99fa44e0ad3aa2a043a865fce6e9098a6. ## Entity Status - Public listing published. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2204a7ef3a119f1804148cd98f27d5d99fa44e0ad3aa2a043a865fce6e9098a6. ## Published Fact - US. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2204a7ef3a119f1804148cd98f27d5d99fa44e0ad3aa2a043a865fce6e9098a6. ## Committee Appointment - Richard A. Zordani: chair, Audit. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. - Kary Eldred: member, Audit. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. - Kevin D. Freeman: member, Audit. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. - Kevin D. Freeman: member, Compensation. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. - Kevin D. Freeman: member, Nominating and Governance. Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d. ## Security Listing - GALT (NASDAQ). Claim: alpha:claim:company:8ec02b3b-19c0-427d-b1c8-424dbbe7ccad:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2204a7ef3a119f1804148cd98f27d5d99fa44e0ad3aa2a043a865fce6e9098a6. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:2204a7ef3a119f1804148cd98f27d5d99fa44e0ad3aa2a043a865fce6e9098a6: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/galectin-therapeutics-inc). - alpha:projection-evidence:document:910d598101b9004aaea5dc048a85ac4219f142602f98fdaa3efe8faf76bb62ff: [GALECTIN THERAPEUTICS INC DEF 14A 2025-10-22](https://www.sec.gov/Archives/edgar/data/1133416/000114036125038875/ny20055081x1_def14a.htm). - alpha:projection-evidence:document:9f663de825e5cf32461de1d780da5fea1dd5881323c905be6a382c6d7aa6b907: [GALT 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1133416/000114036126012155/ef20060823_10k.htm). - alpha:projection-evidence:document:9411ad063b6db76d3e745ef7e598845d34d8f8b33a1d49f6c38ef2f8d2d73959: [GALT 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1133416/000114036126012155/ef20060823_10k.htm). - alpha:projection-evidence:document:55dcc4d5e4ed3af9afd348edbc43fe47338442f6800df0365f5c5bda107509f1: [GALT 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1133416/000114036126012155/ef20060823_10k.htm). - alpha:projection-evidence:ef2a80dac2777fc46e88b18d5de9433d696ebb00ab35d902b28896a9630d1b3d: [Audit](https://www.sec.gov/Archives/edgar/data/1133416/000114036125038875/ny20055081x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/galectin-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/galectin-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/galectin-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/galectin-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-26T19:45:44.575777+00:00; recorded 2026-10-26T19:45:44.575777+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.